论文部分内容阅读
笔者所在的中国北京市的一家股份制公司(白云医药公司(化名)),成立于2004年5月份,期间因为没有实际的业务,作为税务零申报公司,此状况一直持续到2009年,收购了第一份专利权后,有了国家注册的专利产品,从此开始了专利产品的生产、销售。2010年,公司在河北海滨一开发区设立了全资控股子公司,生产、销售公司专利产品,实行财务独立核算,独立纳税。北京作为母公司,提供管理等智力支持。2011年公司的销售额已经达到1.2亿,税后利润
A joint-stock company (Baiyun Pharmaceutical Company (a pseudonym)) in Beijing, China, which was established by the author, was established in May 2004 as a tax zero-filing company because it did not have any actual business. This situation continued until 2009 when the acquisition of the After a patent, with the patented product registered in the country, from the beginning of the production of patented products, sales. In 2010, the Company set up a wholly-owned subsidiary in Hebei Haibin Development Zone to produce and sell the patented products of the Company. It implemented independent financial accounting and independent tax payment. Beijing, as a parent company, provides management and other intellectual support. In 2011 the company’s sales have reached 120 million after-tax profits